Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: A meta-analysis of literature

Head and Neck

Volumn 36, Issue 4, 2014, Pages 596-602

  Yu, Min ^a   Liu, Lei ^a   Liang, Chunshui ^a   Li, Ping ^a   Ma, Xuelei ^a   Zhang, Qiongwen ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

head and neck squamous cell carcinoma; lymphatic vessel density; meta analysis; microvessel density; prognosis

Indexed keywords

CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CAPILLARY DENSITY; CONFIDENCE INTERVAL; DENSITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYMPHATIC VESSEL DENSITY; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW;

HEAD AND NECK SQUAMOUS CELL CARCINOMA; LYMPHATIC VESSEL DENSITY; META-ANALYSIS; MICROVESSEL DENSITY; PROGNOSIS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC VESSELS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 84896119999     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23301     Document Type: Review

References (63)

1. Weidner N, Semple JP, Welch WR, Folkman J,. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
2. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer 1993; 55: 739-744.
3. Macchiarini P, Fontanini G, Squartini F, Angeletti CA, Hardin MJ,. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992; 340: 145-146.
4. Bigler SA, Brawer MK, Deering RE,. Neovascularization in carcinoma of the prostate: a quantitative morphometric study. Mod Pathol 1992; 5: 50A.
5. Bigler SA, Brawer MK, Deering RE, Brown M,. Vessel density in carcinoma of the prostate: comparing organ confined tumors with stage D tumors. Mod Pathol 1993; 6: 56A.
6. Uzzan B, Nicolas P, Cucherat M, Perret GY,. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004; 64: 2941-2955.
7. Kowalski LP, Medina JE,. Nodal metastases: predictive factors. Otolaryngol Clin North Am 1998; 31: 621-637.
8. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-198.
9. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001; 7: 186-191.
10. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20: 672-682.
11. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002; 62: 1315-1320.
12. Wicki A, Christofori G,. The potential role of podoplanin in tumour invasion. Br J Cancer 2007; 96: 1-5.
13. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-256.
14. Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, Ristamäki R,. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003; 63: 1920-1926.
15. Evangelou E, Kyzas PA, Trikalinos TA,. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 2005; 18: 1490-1497.
16. Van der Auwera I, Cao Y, Tille JC, et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006; 95: 1611-1625.
17. Kahn HJ, Marks A,. A new monoclonal antibody, D2-40: for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255-1257.
18. Altman DG,. Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-228.
19. Parmar MK, Torri V, Stewart L,. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834.
20. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
21. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
22. Rubio L, Burgos JS, Morera C, Vera-Sempere FJ,. Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients. Pathol Oncol Res 2000; 6: 210-216.
23. Rubio L, Burgos JS, Lopez-Guerrero JA, Morera C, Vera-Sempere FJ,. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol Res Pract 2002; 198: 97-102.
24. Hegde PU, Brenski AC, Caldarelli DD, et al. Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. Arch Otolaryngol Head Neck Surg 1998; 124: 80-85.
25. Tse GM, Chan AW, Yu KH, et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. Ann Surg Oncol 2007; 14: 3558-3565.
26. Eshghyar N, Mohammadi N, Rahrotaban S, Motahhary P, Vahedi Vaez SM,. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue. Arch Iran Med 2011; 14: 276-280.
27. Koçdor P, Coker I, Bayol U, et al. Quantifying the expression of VEGF using qRT-PCR, evaluation of MVD and their correlation with clinicopathological factors in laryngeal squamous cell carcinoma. Kulak Burun Bogaz Ihtis Derg 2011; 21: 137-144.
28. Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M,. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma. Otolaryngol Head Neck Surg 2009; 141: 478-483.
29. Marioni G, Staffieri A, Manzato E, et al. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011; 137: 175-180.
30. Sakata K, Someya M, Nagakura H, et al. Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. Jpn J Clin Oncol 2008; 38: 402-407.
31. Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, Ristamäki R,. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003; 63: 1920-1926.
32. Heindl LM, Hofmann-Rummelt C, Adler W, et al. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology 2010; 117: 649-658.
33. Sasahira T, Kirita T, Kurihara M, et al. MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma. Eur J Cancer 2010; 46: 2285-2294.
34. Audet N, Beasley NJ, MacMillan C, Jackson DG, Gullane PJ, Kamel-Reid S,. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2005; 131: 1065-1070.
35. Franchi A, Gallo O, Massi D, Baroni G, Santucci M,. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 2004; 101: 973-978.
36. Longatto Filho A, Oliveira TG, Pinheiro C, et al. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J Surg Oncol 2007; 5: 140.
37. Miyahara M, Tanuma J, Sugihara K, Semba I,. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007; 110: 1287-1294.
38. Bolzoni Villaret A, Schreiber A, Facchetti F, et al. Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications. Head Neck 2010; 32: 786-792.
39. Baek SK, Jung KY, Lee SH, et al. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma. Laryngoscope 2009; 119: 1325-1330.
40. Garcia-Carracedo D, Rodrigo JP, Astudillo A, Nieto CS, Gonzalez MV,. Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients. BMC Cancer 2010; 10: 416.
41. Zou JD, Fu HY, Xu W, Lü ZH, Cao HY, Quan XY,. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma]. [Article in Chinese] Zhonghua Zhong Liu Za Zhi 2011; 33: 461-464.
42. Li J, Wang S, Wang S, Zou L, Yan X,. [Prognostic value of synchronized detection of microvascular and lymph vessel density in nasopharyngeal carcinoma]. [Article in Chinese] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 24: 253-257.
43. Zätterström UK, Brun E, Willén R, Kjellén E, Wennerberg J,. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995; 17: 312-318.
44. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ,. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131: 624-630.
45. Kyzas PA, Agnantis NJ, Stefanou D,. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch 2006; 448: 768-775.
46. Liao B, Zhong BL, Li Z, Tian XY, Li Y, Li B,. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J Surg Oncol 2010; 102: 844-851.
47. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D,. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005; 206: 170-177.
48. Zhao D, Pan J, Li XQ, Wang XY, Tang C, Xuan M,. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance. J Oral Pathol Med 2008; 37: 616-625.
49. Yang L, Guo ZM, Chen WK, Zeng ZY,. [Detection and clinical significance of lymphatic microvessel density in supraglottic laryngeal carcinoma]. [Article in Chinese] Ai Zheng 2009; 28: 637-641.
50. Lin JY, Li XY, Dong P, Nakashima T,. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma. J Laryngol Otol 2011; 125: 945-951.
51. Lövey J, Lukits J, Remenár E, et al. Antiangiogenic effects of radiotherapy but not initial microvessel density predict survival in inoperable oropharyngeal squamous cell carcinoma. Strahlenther Onkol 2006; 182: 149-156.
52. Calvin DP, Hammond ME, Pajak TF, et al. Microvessel density ≥60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation therapy Oncology Group (RTOG) 90-03 Trial. Am J Clin Oncol 2007; 30: 406-419.
53. Fernández MM, García-Rozado A, Parente PL,. [Is microvascular density an independent prognostic factor in squamous cell carcinoma of the tongue?] [Article in Spanish] Acta Otorrinolaringol Esp 2007; 58: 341-346.
54. Gleich LL, Biddinger PW, Duperier FD, Gluckman JL,. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 1997; 19: 276-280.
55. Pignataro L, Carboni N, Midolo V, et al. Clinical relevance of microvessel density in laryngeal squamous cell carcinomas. Int J Cancer 2001; 92: 666-670.
56. Teknos TN, Cox C, Barrios MA, et al. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope 2002; 112: 844-851.
57. Foote RL, Weidner N, Harris J, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int J Radiat Oncol Biol Phys 2005; 61: 745-753.
58. Meert AP, Paesmans M, Martin B, et al. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002; 87: 694-701.
59. Des Guetz G, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 94: 1823-1832.
60. Hayes DF, Isaacs C, Stearns V,. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 2001; 6: 375-392.
61. Pietruszewska W, Kobos J, Gryczyński M,. [Microvessel density and endothelial area in assessment of angiogenesis in patients with laryngeal cancer]. [Article in Polish] Otolaryngol Pol 2003; 57: 5-15.
62. Ranieri G, Achille G, Florio G, et al. [Biological-clinical significance of angiogenesis and mast cell infiltration in squamous cell carcinoma of the oral cavity]. [Article in Italian] Acta Otorhinolaryngol Ital 2001; 21: 171-178.
63. Grimes DA, Schulz KF,. Bias and causal associations in observational research. Lancet 2002; 359: 248-252.